GLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD ACCGLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD ACCGLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD ACC

GLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD ACC

No trades
See on Supercharts

Key stats

Assets under management (AUM)
‪5.16 M‬GBP
Fund flows (1Y)
‪884.38 K‬GBP
Dividend yield (indicated)
Discount/Premium to NAV
0.4%

About GLOBAL X ETFS ICAV GENOMICS & BIOTECH UCITS ETF USD ACC

Issuer
Mirae Asset Global Investments Co., Ltd.
Brand
Global X
Expense ratio
0.50%
Inception date
Nov 2, 2021
Index tracked
Solactive Genomics v2 Index - Benchmark TR Net
Management style
Passive
ISIN
IE00BM8R0N95
The Funds investment objective is to generate returns that closely correspond, before fees and expenses, generally to the price and yield performance of the Solactive Genomics v2 Index

Classification

Asset Class
Equity
Category
Sector
Focus
Theme
Niche
Genomic advancements
Strategy
Vanilla
Weighting scheme
Market cap
Selection criteria
Market cap

Returns

1 month3 monthsYear to date1 year3 years5 years
Price performance
NAV total return

What's in the fund

As of June 20, 2024
Exposure type
StocksBonds, Cash & Other
Health Technology
Stocks99.83%
Health Technology95.26%
Commercial Services3.79%
Health Services0.78%
Bonds, Cash & Other0.17%
Cash0.12%
Miscellaneous0.05%
Stock breakdown by region
97%2%
North America97.09%
Asia2.91%
Latin America0.00%
Europe0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings

Dividends

Dividend payout history

Assets under management (AUM)

Fund Flows